Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Item No. 37013

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWInfluenza A nucleoprotein is a viral protein encoded by the NP gene in influenza A RNA.1 It is composed of an RNA-binding domain, oligomerization domains, and polymerase binding domains, and contains two nuclear localization signals and a cytoplasmic accumulation signal, which interacts with host actin.2,3 Influenza A nucleoprotein packages the viral RNA into a helical ribonucleoprotein (RNP) complex that is a template for viral replication. Influenza A is a causative agent of seasonal flu, an acute upper respiratory infection characterized by many symptoms, including fever, dry cough, sore throat, body aches, and a runny nose and can lead to life-threatening complications in individuals with high-risk medical conditions.4 Cayman’s Influenza A Nucleoprotein Monoclonal Antibody (Clone 7B4G10G8) can be used for ELISA and Western blot (WB) applications. This recombinant antibody recognizes nucleoprotein at 53-56 kDa from H1N1 and H7N9.
WARNING This product is not for human or veterinary use.
1. Evolution of influenza A virus nucleoprotein genes: Implications for the origins of H1N1 human and classical swine viruses. J. Virol. 65(7), 3704-3714 (1991).
2. The influenza virus nucleoprotein: A multifunctional RNA-
3. Modulation of nuclear localization of the influenza virus nucleoprotein through interaction with actin filaments. J. Virol. 73(3), 2222-2231 (1999).
4. A narrative review of influenza: A seasonal and pandemic disease. Iran J. Med. Sci. 42(1), 2-13 (2017).